Lead party: Edge Growth Ventures Proprietary Limited (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Aviro Health
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Seed Extension / Pre-Series A · Fund: ASISA ESD Fund
Lead investor/buyer: Edge Growth Ventures Proprietary Limited · Investors/buyers: Edge Growth Ventures Proprietary Limited, Tuksnovation, The Technology Innovation Agency (TIA)
Legal advisers: not identified in the source record.
Source: announced 8 September 2021. Original announcement: avirohealth.com.


